Literature DB >> 31740391

Dose-dependent benzalkonium chloride toxicity imparts ocular surface epithelial changes with features of dry eye disease.

Richard Zhang1, Mijeong Park1, Alexander Richardson1, Nicodemus Tedla1, Elvis Pandzic2, Cintia S de Paiva3, Stephanie Watson4, Denis Wakefield1, Nick Di Girolamo5.   

Abstract

PURPOSE: Inclusion of the preservative benzalkonium chloride (BAC) in ophthalmic solutions is prevalent, despite the noted potential for exacerbating dry eye disease (DED). Whilst studies incorporating BAC have assessed its' effects as a mouse model of DED, the impact on limbal epithelia is under-studied. Our investigation aimed to comprehensively assess the impact of different BAC dosing regimens and their suitability as a mouse model of DED.
METHODS: C57BL/6J mice (n = 72) were administered topical BAC (0.05-0.2%) over 7 days. Fluorescein staining, corneal smoothness index, and immuno-histological analyses were applied to determine architectural and cellular changes on the ocular surface following BAC treatment. The effect of BAC (0.0001-0.01%) on cultivated primary mouse corneo-limbal epithelial cells (CLECs) (n = 6) was examined using morphological and functional assays.
RESULTS: Whilst 0.2% BAC induced severe corneal epithelial defects, 0.1% BAC dispensed once daily over 7 days, induced punctate fluorescein staining without detriment to corneal smoothness. Histochemical staining revealed disorganized basal corneal epithelial cells with enlarged cytoplasmic halos. Furthermore, PAS+ goblet cells were decreased. BAC treatment also modulated K14 expression and distribution within the limbus. In cultured CLEC, BAC triggered cell contraction and vacuolation, increased LDH release and elevated cell necrosis by 4.1-fold. Concentrations of BAC as low as 0.0001% decreased colony formation.
CONCLUSIONS: This study describes how exposing C57BL/6 mice to BAC induce some clinicopathological features of DED seen in humans, and therefore provides the foundations to explore the consequences on the ocular surface, particularly on limbal epithelia and its' stem cells.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31740391     DOI: 10.1016/j.jtos.2019.11.006

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  11 in total

Review 1.  Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms.

Authors:  Xiao Tong; Li Chen; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2022-09-01       Impact factor: 7.169

2.  Dynamic Contrast Microscopic Optical Coherence Tomography As a Novel Method for Assessing Corneal Epithelium During Exposure to Benzalkonium Chloride.

Authors:  Gwen Musial; Tabea Kohlfaerber; Martin Ahrens; Hinnerk Schulz-Hildebrandt; Philipp Steven; Gereon Hüttmann
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

3.  Interleukin-20 is involved in dry eye disease and is a potential therapeutic target.

Authors:  Hsiao-Hsuan Wang; Wei-Yu Chen; Yi-Hsun Huang; Sheng-Min Hsu; Yeou-Ping Tsao; Yu-Hsiang Hsu; Ming-Shi Chang
Journal:  J Biomed Sci       Date:  2022-06-09       Impact factor: 12.771

4.  Protective effects of low-molecular-weight components of adipose stem cell-derived conditioned medium on dry eye syndrome in mice.

Authors:  Yuan-Chieh Lee; Li-Yi Sun; Jia-Rong Zhang
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

5.  Effects of Intravitreal Injection on Ocular Surface and Anterior Segment Parameters.

Authors:  Hafize Gokben Ulutas; Neslihan Parmak Yener
Journal:  Beyoglu Eye J       Date:  2021-06-08

6.  Inter-Eye Comparison of the Ocular Surface of Glaucoma Patients Receiving Surgical and Medical Treatments.

Authors:  Dario Romano; Valentino De Ruvo; Paolo Fogagnolo; Roberta Farci; Luca Mario Rossetti
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

7.  Isotretinoin Impairs the Secretory Function of Meibomian Gland Via the PPARγ Signaling Pathway.

Authors:  Peng Zhang; Lei Tian; Jiayu Bao; Shang Li; Ao Li; Ya Wen; Jingyi Wang; Ying Jie
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.799

8.  Therapeutic Effects of Topical Application of Lycium barbarum Polysaccharide in a Murine Model of Dry Eye.

Authors:  Danyi Qin; Yingping Deng; Lixiang Wang; Hongbo Yin
Journal:  Front Med (Lausanne)       Date:  2022-03-11

9.  Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series.

Authors:  Huai-Lung Chang; Bo-I Kuo; Jo-Hsuan Wu; Wei-Lun Huang; Chien-Chia Su; Wei-Li Chen
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

10.  Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults.

Authors:  Charles Blizzard; Eugene B McLaurin; Arthur Driscoll; Fabiana Q Silva; Srilatha Vantipalli; Jamie Lynne Metzinger; Michael H Goldstein
Journal:  Clin Ophthalmol       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.